Quote:
Originally Posted by cheri
Hi Birgitta
When do you think it will be available? Worth trying to get into a clinical trial?
|
Hey Cheri!
I am aware of two Campath trials for MDS that are currently underway:
This one at the National Institutes of Health, and
This one at MD Anderson in Houston.
Each has its own criteria for including patients, and they are trying different dosages and protocols for administering the drug.
Campath is FDA approved for the treatment of some CLL patients but not yet for MDS. That means your doc could get it, but getting insurance to cover it might be a problem.
Take Care!
Greg
__________________
Greg, 59, dx MDS RCMD Int-1 03/10, 8+ & Dup1(q21q31). NIH Campath 11/2010. Non-responder. Tiny telomeres. TERT mutation. Danazol at NIH 12/11. TX independent 7/12. Pancreatitis 4/15. 15% blasts 4/16. DX RAEB-2. Beginning Vidaza to prep for MUD STC. Check out my blog at
www.greghankins.com